MAXLINEAR, INC. | |||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
(in thousands, except per share data) | |||||||
Years Ended | |||||||
December 31, 2017 | December 31, 2016 | ||||||
Net revenue | $ | 420,318 | $ | 387,832 | |||
Cost of net revenue | 212,355 | 157,842 | |||||
Gross profit | 207,963 | 229,990 | |||||
Operating expenses: | |||||||
Research and development | 112,279 | 97,745 | |||||
Selling, general and administrative | 105,831 | 64,454 | |||||
IPR&D impairment losses | 2,000 | 1,300 | |||||
Restructuring charges | 9,524 | 3,432 | |||||
Total operating expenses | 229,634 | 166,931 | |||||
Income (loss) from operations | (21,671 | ) | 63,059 | ||||
Interest income | 274 | 572 | |||||
Interest expense | (10,378 | ) | (104 | ) | |||
Other income (expense), net | (2,223 | ) | 163 | ||||
Total interest and other income (expense), net | (12,327 | ) | 631 | ||||
Income (loss) before income taxes | (33,998 | ) | 63,690 | ||||
Income tax provision (benefit) | (24,811 | ) | 2,398 | ||||
Net income (loss) | $ | (9,187 | ) | $ | 61,292 | ||
Net income (loss) per share: | |||||||
Basic | $ | (0.14 | ) | $ | 0.96 | ||
Diluted | $ | (0.14 | ) | $ | 0.91 | ||
Shares used to compute net income (loss) per share: | |||||||
Basic | 66,252 | 63,781 | |||||
Diluted | 66,252 | 67,653 | |||||
MAXLINEAR, INC. | |||||||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
(in thousands) | |||||||||||
Three Months Ended | |||||||||||
December 31, 2017 | September 30, 2017 | December 31, 2016 | |||||||||
Operating Activities | |||||||||||
Net income (loss) | $ | (19,448 | ) | $ | (9,167 | ) | $ | 8,348 | |||
Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||||||||||
Amortization and depreciation | 20,236 | 21,342 | 7,960 | ||||||||
Impairment of IPR&D assets | — | 2,000 | — | ||||||||
Provision for losses on accounts receivable | — | 46 | — | ||||||||
Amortization of investment premiums, net | — | — | 74 | ||||||||
Amortization of inventory step-up | 9,715 | 10,207 | 2,652 | ||||||||
Amortization of debt issuance costs | 287 | 301 | — | ||||||||
Stock-based compensation | 7,770 | 7,796 | 5,290 | ||||||||
Deferred income taxes | 16,650 | (1,163 | ) | (114 | ) | ||||||
(Gain) loss on disposal of property and equipment | (33 | ) | 286 | 318 | |||||||
(Gain) loss on foreign currency | 738 | 733 | (282 | ) | |||||||
Excess tax benefits on stock-based awards | (1,961 | ) | (841 | ) | (2,249 | ) | |||||
Change in fair value of contingent consideration | — | — | 11 | ||||||||
Impairment of leases | — | — | 388 | ||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 9,492 | 7,063 | (815 | ) | |||||||
Inventory | 543 | 5,060 | 2,882 | ||||||||
Prepaid expenses and other assets | (424 | ) | 2,374 | 767 | |||||||
Accounts payable, accrued expenses and other current liabilities | (2,494 | ) | (17,453 | ) | 752 | ||||||
Accrued compensation | 1,351 | 1,498 | 2,252 | ||||||||
Deferred revenue and deferred profit | (12,862 | ) | 3,907 | 697 | |||||||
Accrued price protection liability | (6,658 | ) | 3,606 | (1,936 | ) | ||||||
Other long-term liabilities | (1,159 | ) | 144 | 608 | |||||||
Net cash provided by operating activities | 21,743 | 37,739 | 27,603 | ||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | (3,070 | ) | (2,500 | ) | (1,684 | ) | |||||
Proceeds from sale of property and equipment | 30 | — | — | ||||||||
Purchases of intangible assets | — | (53 | ) | — | |||||||
Purchases of available-for-sale securities | — | — | (10,044 | ) | |||||||
Maturities of available-for-sale securities | — | — | 10,185 | ||||||||
Net cash used in investing activities | (3,040 | ) | (2,553 | ) | (1,543 | ) | |||||
Financing Activities | |||||||||||
Net proceeds from issuance of common stock | 2,960 | 1,074 | 2,199 | ||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,718 | ) | (1,426 | ) | (1,132 | ) | |||||
Repayment of debt | (20,000 | ) | (50,000 | ) | — | ||||||
Net cash provided by (used in) financing activities | (18,758 | ) | (50,352 | ) | 1,067 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 371 | (829 | ) | (307 | ) | ||||||
Increase (decrease) in cash, cash equivalents and restricted cash | 316 | (15,995 | ) | 26,820 | |||||||
Cash, cash equivalents and restricted cash at beginning of period | 74,096 | 90,091 | 56,076 | ||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 74,412 | $ | 74,096 | $ | 82,896 | |||||